Latest News and Press Releases

Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging or previously undruggable disease targets Financing...

As per the report by Visiongain, the Human Microbiome Market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25.0 % during the forecast period 2023-2033.  Visiongain has...

As per the report by Visiongain, the Nasal Drug Delivery Technology Market was valued at US$71.0 billion in 2022 and is projected to grow at a CAGR of 7.5% during the forecast period 2023-2033.  ...

As per the report by Visiongain, the Allergy Immunotherapy Market was valued US$1,907.5 million in 2022 and is projected to grow at a CAGR of 7.6% during the forecast period 2023-2033.  Visiongain...

As per the report by Visiongain, the Menopause Market was valued at US$17.33 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.  Visiongain has...

As per the report by Visiongain, the Global Dental Consumables Market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8.0% from 2023 to 2033.  Visiongain has published...

As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033.  Visiongain has...

Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...

VANCOUVER, British Columbia, May 04, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), today announced that it has entered into a...

Visiongain has published a new report entitled Nasal Drug Delivery Technology 2023-2033: Forecasts by Containers (Pressurized Containers, Non-pressurized Containers), by System (Nasal Bi Dose, Nasal...